Contact this trialFirst, we need to learn more about you.
Pro-Drug
BHV-4157 for Ataxia
Recruiting2 awardsPhase 3
Los Angeles, California
This trial is to test the efficacy of BHV-4157 in treating cerebellar ataxia in adults. Patients will be required to visit UCLA five times over the course of the 12 weeks--once for screening, once for baseline testing, and then once every four weeks. There is also the option to extend the trial for an additional 36 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.